Get the tools used by (smart)2 investors.
SP500 1.8%DOW 1.6%FTSE 100 0.8%NIKKEI -2.5%OIL 1.8%GOLD 1.9%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Levered Free Cash Flow

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

22.75
Price
–
Fair Value
–
Upside
13.90 - 29.18
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on 's Levered Free Cash Flow:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20241 B2 B3 B
Performance Summary
  • Genomma Lab Internacional SAB De CV's latest twelve months levered free cash flow is 2.763 billion
  • Genomma Lab Internacional SAB De CV's levered free cash flow for fiscal years ending December 2020 to 2024 averaged 1.656 billion.
  • Genomma Lab Internacional SAB De CV's operated at median levered free cash flow of 1.652 billion from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Genomma Lab Internacional SAB De CV's levered free cash flow peaked in December 2024 at 2.763 billion.
  • Genomma Lab Internacional SAB De CV's levered free cash flow hit its 5-year low in December 2021 of 838.1 million.
  • Genomma Lab Internacional SAB De CV's levered free cash flow decreased in 2021 (838.1 million, -17.6%) and increased in 2020 (1.018 billion, +532.2%), 2022 (1.652 billion, +97.1%), 2023 (2.009 billion, +21.6%), and 2024 (2.763 billion, +37.6%).

How does Genomma Lab Int's Levered Free Cash Flow benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Genomma Lab Internacional SAB De CV because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Genomma Lab Int Levered Free Cash Flow Benchmarks
NameTickerLevered Free Cash Flow
Moberg Pharma AB (publ)DB:MB8-1.437 M
HealthcareSECTOR:HLTH.MX57.485 M
Orion OyjDB:OFK231.1 M
Genomma Lab Internacional SAB De CVBMV:LABB2.763 B
Perrigo Company plcBMV:PRGON4.823 B
Zoetis Inc.BMV:ZTS*47.914 B
Bayer AGBMV:BAYNN99.143 B
GSK plcBMV:GSK1N134.6 B
SanofiBMV:SAN1N158.7 B
Pfizer IncBMV:PFE*205.1 B
China Resources Pharmaceutical Group LtdSEHK:3320NA
Consun Pharmaceutical Group LtdSEHK:1681NA

Metric Usage: Levered Free Cash Flow

Hide this widget
fcf_levered
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Levered Free Cash Flow in the financials category include:

  • Insurance Settlements - This item represents Proceeds from insurance claims received by a company from its insurance carrier.
  • Stock-Based Comp, SG&A Expense - This item represents the stock based compensation included in SG&A when available.
  • Cash And Short Term Investments - Cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items. Cash equivalents are extremely liquid investments with low risk that can immediately be converted to cash. Includes cash restricted for specific purposes.
  • Minority Interest, Total - The book value of the reporting company's share of ownership in another company.
View Full List

Search for metric or datapoint

Levered Free Cash Flow

The sum of cash from operations and capital expenditures

Definition of Levered Free Cash Flow

Hide this widget

The Levered Free Cash Flow is calculated as follows:

Cash From Operations
(-) Capital Expenditures
(=) Levered Free Cash Flow

Read more about cash from operations and capital expenditures

Click the link below to download a spreadsheet with an example Levered Free Cash Flow calculation for Genomma Lab Internacional SAB De CV below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-1.044 B-393.8 M256.2 M1.476 B050100150

The chart above depicts the distribution of levered free cash flow for companies operating in the Healthcare sector in the Developing economic region. Over 990 companies were considered in this analysis, and 698 had meaningful values. The average levered free cash flow of companies in the sector is 107 M with a standard deviation of 431.4 M.

Genomma Lab Internacional SAB De CV's Levered Free Cash Flow of 2.763 B is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:

Levered Free Cash Flow In The Healthcare Sector
Economic Risk RegionDeveloping
Total Constituents993
Included Constituents698
Min-983.8 M
Max1.416 B
Median35.46 M
Mean107 M
Standard Deviation431.4 M

You can find companies with similar levered free cash flow using this stock screener.

All rights reserved. Terms Of Use